Loss of muscle mass during preoperative chemotherapy predicts worse recurrence-free survival in patients with resectable colorectal liver metastases. (March 2018) - Okuno, M.; Goumard, C.; Kopetz, S.; Simoneau, E.B.; Mizuno, T.; Omichi, K.; Tzeng, C.W.D.; Chun, Y.S.; Lee, J.E.; Vauthey, J.N.; Aloia, T.A.; Conrad, C.